About IQGEN-X Pharma
IQGEN-X Pharma is a company based in Mumbai (India) founded in 2016. IQGEN-X Pharma has raised $1.35 million across 1 funding round from investors including ACG Group. The company has 34 employees as of April 03, 2024. IQGEN-X Pharma offers products and services including Formulation Development and ANDA Filing. IQGEN-X Pharma operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
- Headquarter Mumbai, India
- Employees 34 as on 03 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iqgen-X Pharma Private Limited
- Date of Incorporation 13 Oct, 2016
- Jurisdiction Navi Mumbai, Maharashtra, India
-
Annual Revenue
$1.02 M (USD)-13.64as on Mar 31, 2023
-
Net Profit
-$31.12 K (USD)86.35as on Mar 31, 2023
-
EBITDA
$120.27 K (USD)373.39as on Mar 31, 2023
-
Total Equity Funding
$1.35 M (USD)
in 1 rounds
-
Latest Funding Round
$1.35 M (USD), Seed
Oct 28, 2020
- Investors
-
Employee Count
34
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IQGEN-X Pharma
IQGEN-X Pharma offers a comprehensive portfolio of products and services, including Formulation Development and ANDA Filing.
Service for developing pharmaceutical formulations and scale-up.
Assistance in filing Abbreviated New Drug Applications for generics.
Funding Insights of IQGEN-X Pharma
IQGEN-X Pharma has successfully raised a total of $1.35M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.35 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IQGEN-X Pharma
IQGEN-X Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ACG Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer & supplier of solid dosage products, pharmaceutical machinery and equipment, and packaging solutions
|
Locked | Locked | Locked |
Investor details for IQGEN-X Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IQGEN-X Pharma
Investment portfolio details for IQGEN-X Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IQGEN-X Pharma
Detailed financials for IQGEN-X Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iqgen-X Pharma Comparisons
Peer comparison for IQGEN-X Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IQGEN-X Pharma
IQGEN-X Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and development research services are provided.
|
Detailed competitors of IQGEN-X Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iqgen-X Pharma
Complete news archive for IQGEN-X Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IQGEN-X Pharma
IQGEN-X Pharma was founded in 2016 and raised its 1st funding round 4 years after it was founded.
IQGEN-X Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
IQGEN-X Pharma is a funded company, having raised a total of $1.35M across 1 funding round to date.
As of Apr 03, 2024, the latest employee count at IQGEN-X Pharma is 34.
Annual revenue of IQGEN-X Pharma is $1.02M as on Mar 31, 2023.
IQGEN-X Pharma was established in 2016 in Mumbai, India, within the pharmaceutical sector. Finished formulations, including solid and sterile liquids, are developed and produced for multiple therapeutic categories. Solid options encompass quick-release, conventional-release, extended-release tablets, oral suspensions, nasal sprays, and dry powder inhalers. Operations focus on these formats to support drug delivery needs.
IQGEN-X Pharma's top competitors include Evotec, Crown Bioscience and NIH.
IQGEN-X Pharma offers Formulation Development and ANDA Filing.
IQGEN-X Pharma has 1 investor. Key investors include ACG Group.
The valuation of IQGEN-X Pharma is $4.2M as of Oct 2020.